Hauptinvestoren

  • LSP Curetis Pooling - 18,68%
  • C-Partners (ex Aeris Capital Equity Investments) - 14,99%
  • Forbion Capital Fund 2 Cooperatief - 9,18%
  • HBM BioCapital 2 Management - 8,67%
  • Aviva Investors Global Services Ltd- 7,45%
  • Roche Finanz AG - 6,39%
  • Federal Republic of Germany - 6,14%
  • CD-Venture GmbH - 2,97%
  • BioMedPartners - 2,02%

Letztes Update: 13. März 2018